Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses

被引:18
作者
Chen, XM
Rock, MT
Hammonds, J
Tartaglia, J
Shintani, A
Currier, J
Slike, B
Crowe, JE
Marovich, M
Spearman, P
机构
[1] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA
[4] Aventis Pasteur, Toronto, ON, Canada
[5] US Mil Acad, HIV Res Program, Rockville, MD USA
关键词
D O I
10.1128/JVI.79.9.5537-5547.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Live-vector-based human immunodeficiency virus (HIV) vaccines are an integral part of a number of HIV vaccine regimens currently under evaluation. Live vectors that carry an intact gag gene are capable of eliciting HIV pseudovirion particle formation from infected host cells. The impact of pseudovirion particle formation on the immune response generated by live HIV vaccine vectors has not been established. In this study, a canarypox HIV vaccine candidate vector expressing HIV gag and env genes, vCP205, was modified by the introduction of a glycine-to-alanine coding change in the N-terminal myristylation site of gag to create Myr(-) vCP205. This substitution effectively eliminated particle formation without altering the level of protein production. vCP205 and Myr- vCP205 were then directly compared for the ability to induce HIV-specific immune responses in mice. The particle-competent vector vCP205 elicited higher levels of CD8(+) T-cell responses, as indicated by gamma interferon enzyme-linked immunospot (ELISPOT) assay and intracellular cytokine staining. Humoral responses to Gag and Env were also markedly higher from animals immunized with the particle-competent vector. Furthermore, HIV-specific CD4(+) T-cell responses were greater among animals immunized with the particle-competent vector. Using a human dendritic cell model of antigen presentation in vitro, vCP205 generated greater ELISPOT responses than Myr(-) vCP205. These results demonstrate that pseudovirion particle production by live-vector HIV vaccines enhances HIV-specific cellular and humoral immune responses.
引用
收藏
页码:5537 / 5547
页数:11
相关论文
共 49 条
[41]   Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity [J].
Shiver, JW ;
Fu, TM ;
Chen, L ;
Casimiro, DR ;
Davies, ME ;
Evans, RK ;
Zhang, ZQ ;
Simon, AJ ;
Trigona, WL ;
Dubey, SA ;
Huang, LY ;
Harris, VA ;
Long, RS ;
Liang, XP ;
Handt, L ;
Schleif, WA ;
Zhu, L ;
Freed, DC ;
Persaud, NV ;
Guan, L ;
Punt, KS ;
Tang, A ;
Chen, MC ;
Wilson, KA ;
Collins, KB ;
Heidecker, GJ ;
Fernandez, VR ;
Perry, HC ;
Joyce, JG ;
Grimm, KM ;
Cook, JC ;
Keller, PM ;
Kresock, DS ;
Mach, H ;
Troutman, RD ;
Isopi, LA ;
Williams, DM ;
Xu, Z ;
Bohannon, KE ;
Volkin, DB ;
Montefiori, DC ;
Miura, A ;
Krivulka, GR ;
Lifton, MA ;
Kuroda, MJ ;
Schmitz, JE ;
Letvin, NL ;
Caulfield, MJ ;
Bett, AJ ;
Youil, R .
NATURE, 2002, 415 (6869) :331-335
[42]   Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen [J].
Sigal, LJ ;
Crotty, S ;
Andino, R ;
Rock, KL .
NATURE, 1999, 398 (6722) :77-80
[43]   IDENTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG PROTEIN DOMAINS ESSENTIAL TO MEMBRANE-BINDING AND PARTICLE ASSEMBLY [J].
SPEARMAN, P ;
WANG, JJ ;
VANDERHEYDEN, N ;
RATNER, L .
JOURNAL OF VIROLOGY, 1994, 68 (05) :3232-3242
[44]   HIV vaccine development: Lessons from the past and promise for the future [J].
Spearman, P .
CURRENT HIV RESEARCH, 2003, 1 (01) :101-120
[45]   Effects of the selective activation of 5-HT3 receptors on sleep:: a polysomnographic study in healthy volunteers [J].
Staner, L ;
Linker, T ;
Toussaint, M ;
Danjou, P ;
Roegel, JC ;
Luthringer, R ;
Le Fur, G ;
Macher, JP .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2001, 11 (04) :301-305
[46]   AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding [J].
Strack, B ;
Calistri, A ;
Craig, S ;
Popova, E ;
Göttlinger, HG .
CELL, 2003, 114 (06) :689-699
[47]  
Tartaglia J, 1998, AIDS RES HUM RETROV, V14, pS291
[48]   The protein network of HIV budding [J].
von Schwedler, UK ;
Stuchell, M ;
Müller, B ;
Ward, DM ;
Chung, HY ;
Morita, E ;
Wang, HE ;
Davis, T ;
He, GP ;
Cimbora, DM ;
Scott, A ;
Kräusslich, HG ;
Kaplan, J ;
Morham, SG ;
Sundquist, WI .
CELL, 2003, 114 (06) :701-713
[49]   FORM, FUNCTION, AND USE OF RETROVIRAL GAG PROTEINS [J].
WILLS, JW ;
CRAVEN, RC .
AIDS, 1991, 5 (06) :639-654